Houston Methodist 13th Annual Houston Methodist Cancer Symposium 2025

Event starts:  08/15/2025 – 8:00am CDT

Event ends: 08/15/2025 – 5:00pm CDT

This annual symposium, dedicated to the science and clinical care of solid and hematologic malignancies, brings together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical, and epidemiological research. A wide range of topics will be covered, from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine.

Target Audience

Physician scientists, practicing oncologists, physician assistants, advanced nurse practitioners, oncology nurses, residents, fellows, medical students, allied health care professionals and clinical research associates will benefit from this course.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

Discuss the fundamental mechanisms of cellular immunotherapy in hematologic malignancies
Describe the approved cell therapy options in hematologic malignancies including CAR-T cell
Identify new cellular therapies in the pipeline for these diseases

The Houston Methodist 13th Annual Cancer Symposium (2025) is best for clinicians, researchers, and care teams seeking state-of-the-art updates spanning solid and hematologic malignancies, with a practical focus on translating innovations into current practice.
Who should attend

Medical, surgical, and radiation oncologists: Evidence-based updates and implementation strategies across tumor types
Pathologists and radiologists: Translational science that impacts diagnostics and treatment planning
Hematologists and bone marrow transplant teams: Advances in hematologic malignancies and supportive care
Nurses, pharmacists, and advanced practice providers: Multiprofessional perspectives and clinical takeaways for daily care
Researchers and trainees: Opportunities to present abstracts and engage with cutting-edge cancer science

What you’ll learn

Innovative translational science: From bench discoveries to bedside applications in oncology
Clinical updates: Strategies for integrating new evidence into treatment pathways for solid and hematologic cancers
Outcomes-focused practice: Content designed to enhance competency and real-world patient care

+ Topics:

13th Annual Houston Methodist Cancer Symposium
August 15, 2025

Time
Presentation
Speaker

7:30 AM
Registration

8:20 AM
Welcome

8:30 AM
Oncology Keynote: Developing Innovative Therapy
Lawrence Einhorn, MD

9:15 AM
Question and Answer Session

9:25 AM
Renal Cell Carcinoma State of Research: Accomplishments and Future Directions
Nizar Tannir, MD, FACP

9:55 AM
Question and Answer Session

10:00 AM
Break and Exhibits

10:25 AM
Advances in the Management of Metastatic Castration Sensitive Prostate Cancer: What the Future Holds
Jorge Garcia, MD, MSc, FACP

10:55 AM
Question and Answer Session

11:00 AM
Integrating Cardiometabolic Risk Stratification into Cancer Care
Sadeer Al – Kindi, MD, FACC

11:30 AM
Question and Answer Session

11:35 AM
Lunch Keynote I: CAR T Therapy: Milestones in Cancer Immunotherapy and New Horizons in Targeting PSMA
Bin He, PhD

12:05 PM
Lunch Keynote II: Trauma Informed Care in Oncology
Jessica Blanc, MSW, LCSW

12:35 PM
Lunch and Exhibits

1:00 PM
AI foundation models in the front of biomedicine
Guangyu Wang, PhD

1:45 PM
Question and Answer Session

1:55 PM
AI in Healthcare: Enhancing Diagnosis and Decision-Making
Sunil Mathur, PhD

2:25 PM
Question and Answer Session

2:30 PM
Break and Exhibits

2:45 PM
Current and Future Technologies and Artificial Itelligence in Diagnostic Hematopathology
John Rogers, MD

3:15 PM
Question and Answer Session

3:20 PM
Break and Exhibits

3:50 PM
Abstract Winner Discussions

4:30 PM
Question and Answer Session

4:45 PM
Adjournment